Rimonyx Pharmaceuticals Ltd.

Rimonyx Pharmaceuticals Ltd. (Rimonyx) is a start-up stage bio-pharmaceutical company, engaged in discovery and development of innovative anti-inflammatory therapeutics. The company makes use of its Glycosaminoglycans (SMIG) platform in identifying the new class of drugs, where the SMIG platform is based on analysis of clinically-proven drugs and involves rational drug design. Many lead compounds against pro-inflammatory chemokines and cytokines are being discovered by Rimonyx to meet the growing need of the market. Its platform is also used to develop vaccines for cancer, amyloid disorders, and viral diseases. The company is actively seeking corporate partnerships to develop and commercialize its drug discovery programs. Rimonyx is headquartered in Ness-Ziona, Israel.

Street: 
Rabin Science Park
City: 
Ness-Ziona
Postcode: 
70400
Federal State : 
Israel
WebSite: 
www.rimonyx.com
Fax: 
972-8-9402082

Company Index Score

Current Index Score Historical Index Score
  • Rimonyx Pharmaceuticals Ltd. currently scores 50 % in the index.
  • Rimonyx Pharmaceuticals Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Rimonyx Pharmaceuticals Ltd. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets